Drugstore Co., Ltd. (YSB) will hold its Annual General Meeting on May 23, 2024 at Guangzhou, China. The meeting will discuss a number of resolutions including the audit of the 2023 Audited Financial Statements, the Board's Report and the Auditor's Report. In addition, shareholders will vote on matters such as the re-election of Mr. Zhu Ziyang as a non-executive director, Mr. Zhao Hongqiang as an independent non-executive director, and authorize the Board of Directors to determine the directors' remuneration. THE MEETING WILL ALSO DISCUSS THE RENEWAL OF DEXIN ACCOUNTANTS AS ACTING AUDITORS AND GRANTING THE DIRECTORS GENERAL MANDATES TO REPURCHASE AND ISSUE SHARES. Shareholders are required to submit the Proxy Form by 21 May 2024 in order to vote at the General Meeting.

Drugstore Co., Ltd. (YSB) will hold its Annual General Meeting on May 23, 2024 at Guangzhou, China. The meeting will discuss a number of resolutions including the audit of the 2023 Audited Financial Statements, the Board's Report and the Auditor's Report. In addition, shareholders will vote on matters such as the re-election of Mr. Zhu Ziyang as a non-executive director, Mr. Zhao Hongqiang as an independent non-executive director, and authorize the Board of Directors to determine the directors' remuneration. THE MEETING WILL ALSO DISCUSS THE RENEWAL OF DEXIN ACCOUNTANTS AS ACTING AUDITORS AND GRANTING THE DIRECTORS GENERAL MANDATES TO REPURCHASE AND ISSUE SHARES. Shareholders are required to submit the Proxy Form by 21 May 2024 in order to vote at the General Meeting.